Medicine and Dentistry
Epileptic Seizure
100%
Brain Disease
84%
Disease
67%
Partial Seizure
52%
Diseases
31%
Hypotonia
30%
SCN8A
30%
Genotype Phenotype Correlation
30%
GRIN2A
30%
NMDA Receptor
30%
Comorbidity
30%
Amitriptyline
30%
Retrospective Cohort Study
30%
Dysmorphic Feature
30%
Genetic Screening
30%
Molecular Diagnosis
30%
Congenital Malformation
30%
Posterior Fossa
30%
Brain Development
25%
Generalised Epilepsy
24%
N Methyl-D-Aspartate Receptor
20%
Targeted Therapy
20%
Aspartic Acid
20%
Ionotropic Receptor
20%
GRIN2B
20%
Receptor
20%
Epileptic Spasms
15%
Lennox-Gastaut Syndrome
15%
Tonic-Clonic Seizure
15%
Epilepsy Syndromes
15%
Drug Resistant Epilepsy
15%
Clinical Genetics
15%
Protein A
15%
Respiratory Distress
15%
Protein Binding
15%
Seizure Types
15%
Ascending Aorta
15%
Clinical Feature
15%
Systematic Review
15%
Treatment Response
15%
Haploinsufficiency
15%
Purine
15%
Autosomal Recessive Inheritance
15%
Clinical Finding
15%
Patent Ductus Arteriosus
15%
Motor Performance
13%
Steady State
12%
Epileptic Absence
12%
Sodium Channel Blocker
12%
Epileptic Discharge
12%
Neuroscience
Brain Disease
68%
Hypotonia
30%
NMDA Receptor
30%
Aspartic Acid
30%
Generalised Epilepsy
30%
SCN8A
30%
Comorbidity
30%
Amitriptyline
30%
Brain Development
22%
GRIN2A
22%
Focal Epilepsy
22%
Receptor
22%
Haploinsufficiency
15%
Seizure Types
15%
Tonic-Clonic Seizure
15%
Purine
15%
Protein Binding
15%
Protein A
15%
Ionotropic Glutamate Receptor
15%
Ionotropic Receptor
15%
GRIN2B
15%
Sodium Channel Blocker
15%
Epileptic Absence
15%
Sodium Channel Nav1.6
7%
Anti-Seizure Medication
7%
Ligand-Gated Ion Channel
7%
GRIN1
7%
Receptor Gene
7%
Serine
7%
Cognitive Function
7%
Receptor Subunit
7%
Memantine
7%
Sodium Channel
7%
Tetrodotoxin
7%
Neurodevelopmental Disorder
7%
Firing Rate
7%
Patch Clamp
7%
Antiseizure Medication
7%
Neuroblastoma
7%
Synaptic Transmission
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cenobamate
61%
Brain Disease
48%
Focal Epilepsy
43%
Cohort Study
33%
Aspartic Acid
30%
Fenfluramine
30%
Severe Myoclonic Epilepsy in Infancy
30%
Amitriptyline
30%
N Methyl Dextro Aspartic Acid Receptor
30%
Vinpocetine
30%
Receptor
27%
Ionotropic Receptor
15%
Memantine
7%
Receptor Subunit
7%
Serine
7%
Drug Resistant Epilepsy
7%
Intractable Epilepsy
7%
Diseases
7%
Ligand Gated Ion Channel
7%
Tolerability
6%
Sodium Channel Blocking Agent
5%
Dietary Supplement
5%
Developmental Delay
5%
Intellectual Impairment
5%
Retrospective Study
5%
Voltage Gated Sodium Channel
5%
Vincamine
5%